Pesquisas alternativas:
grade oral » graders oral (Expandir a Pesquisa), guide oral (Expandir a Pesquisa), made oral (Expandir a Pesquisa)
trad ngon » tran ngon (Expandir a Pesquisa)
nay clamp » dnan clamp (Expandir a Pesquisa), a clamp (Expandir a Pesquisa), dna clamp (Expandir a Pesquisa)
j grade » j grande (Expandir a Pesquisa), j grace (Expandir a Pesquisa), j grabe (Expandir a Pesquisa)
oral d » oral de (Expandir a Pesquisa), oral da (Expandir a Pesquisa), oral del (Expandir a Pesquisa)
j nay » j nagy (Expandir a Pesquisa), _ nay (Expandir a Pesquisa)
d non » _ non (Expandir a Pesquisa), a non (Expandir a Pesquisa), i non (Expandir a Pesquisa)
grade oral » graders oral (Expandir a Pesquisa), guide oral (Expandir a Pesquisa), made oral (Expandir a Pesquisa)
trad ngon » tran ngon (Expandir a Pesquisa)
nay clamp » dnan clamp (Expandir a Pesquisa), a clamp (Expandir a Pesquisa), dna clamp (Expandir a Pesquisa)
j grade » j grande (Expandir a Pesquisa), j grace (Expandir a Pesquisa), j grabe (Expandir a Pesquisa)
oral d » oral de (Expandir a Pesquisa), oral da (Expandir a Pesquisa), oral del (Expandir a Pesquisa)
j nay » j nagy (Expandir a Pesquisa), _ nay (Expandir a Pesquisa)
d non » _ non (Expandir a Pesquisa), a non (Expandir a Pesquisa), i non (Expandir a Pesquisa)
1
Por Abramson, J.S., Takvorian, R.W., Fisher, D.C., Feng, Y., Jacobsen, E.D., Brown, J.R., Barnes, J.A., Neuberg, D.S., Hochberg, E.P.
Publicado no Leuk Lymphoma (2013)
“...We conducted a phase 1 trial evaluating the oral nucleoside analogue clofarabine in patients...”Publicado no Leuk Lymphoma (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Picart, T, Barritault, M, Tabouret, E, Idbaih, A, Izquierdo Gracia, C, Poncet, D, Honnorat, J, Meyronet, D, Guyotat, J, Ducray, F
Publicado no Neuro Oncol (2019)
Assuntos:
“...Oral Presentations...”Publicado no Neuro Oncol (2019)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Cunningham, D, Gilchrist, N L, Cowan, R A, Forrest, G J, McArdle, C S, Soukop, M
Publicado em 1985
“...Ten patients with low grade non-Hodgkin's lymphoma (seven follicular small cleaved and three small...”Publicado em 1985
Obter o texto integral
Obter o texto integral
Artigo
4
Por Izquierdo, C, Barritault, M, Poncet, D, Cartalat, S, Joubert, B, Bruna, J, Jouanneau, E, Guyotat, J, Vasiljevic, A, Fenouil, T, Berthezène, Y, Honnorat, J, Meyronet, D, Ducray, F
Publicado no Neuro Oncol (2018)
Assuntos:
“...Oral Presentations...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
5
Por Krzakowski, M., Bennouna, J., Dansin, E., Kowalski, D., Hiret, S., Penel, N., Favrel, S., Tourani, J. M.
Publicado em 2013
“... patient) and related death (1 patient). Non-haematologic grade 3/4 toxicities included fatigue, condition...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Woll, P. J., Crowther, D., Johnson, P. W., Soukop, M., Harper, P. G., Harris, M., Brampton, M. H., Newlands, E. S.
Publicado em 1995
“...Temozolomide, an imidazotetrazine derivative, was given to 18 patients with low-grade non-Hodgkin...”Publicado em 1995
Obter o texto integral
Obter o texto integral
Artigo
7
Por STATHOPOULOS, G.P., TRAFALIS, D., DIMITROULIS, J., ATHANASIOU, A., KOUTANTOS, J., ANAGNOSTOPOULOS, A.
Publicado em 2010
“...Erlotinib is an oral, small-molecule targeting therapy that inhibits epidermal growth factor...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Younan, N, Douzane, H, Duran-Pena, A, Nichelli, L, Garcilazo, Y, Dehais, C, Ducray, F, Carpentier, C, Mokhtari, K, Figarella-Branger, D, Delattre, J, Idbaih, A, Alentorn, A
Publicado no Neuro Oncol (2019)
Assuntos:
“...Oral Presentations...”Publicado no Neuro Oncol (2019)
Obter o texto integral
Obter o texto integral
Artigo
9
Por Anderson, H., Scarffe, J. H., Sutton, R. N., Hickmott, E., Brigden, D., Burke, C.
Publicado em 1984
“... and prednisolone (VAP) for high grade lymphoma or acute lymphoblastic leukaemia were entered into a double blind...”Publicado em 1984
Obter o texto integral
Obter o texto integral
Artigo
10
Por Vatca, M., Lucas, J.T., Laudadio, J., D’Agostino, R.B., Waltonen, J.D., Sullivan, C.A., Rouchard-Plasser, R., Matsangou, M., Browne, J.D., Greven, K.M., Porosnicu, M.
Publicado em 2014
“... patients had a 6.86-fold increase in the risk of having severe, grade 3–4 mucositis. This effect...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...1 The clinical and haemodynamic effects of low doses of the oral converting-enzyme inhibitor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Bromberg, J E C, Issa, S, Bakunina, K, Minnema, M C, Seute, T, Cull, G, van den Bent, M J, Gonzales, M, de Jong, D, Doorduijn, J K
Publicado no Neuro Oncol (2018)
Assuntos:
“...Oral Presentations...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
13
“... and long-lasting orally-active non-peptide BK antagonists, which may be useful for the management...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Spencer, Sally, Felix, Lambert M, Milan, Stephen J, Normansell, Rebecca, Goeminne, Pieter C, Chalmers, James D, Donovan, Tim
Publicado no Cochrane Database Syst Rev (2018)
“... risk of developing antibiotic resistance when compared with orally administered antibiotics. However...”Publicado no Cochrane Database Syst Rev (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Wang, S.F., Wang, Q., Jiao, L.J., Huang, Y.L., Garfield, D., Zhang, J., Xu, L.
Publicado no Curr Oncol (2016)
“...OBJECTIVE: Traditional Chinese Medicine (tcm) is used in China as part of the treatment for non...”Publicado no Curr Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Lacouture, M. E., Keefe, D. M., Sonis, S., Jatoi, A., Gernhardt, D., Wang, T., Doherty, J. P., Giri, N., Nadanaciva, S., O'Connell, J., Sbar, E., Piperdi, B., Garon, E. B.
Publicado no Ann Oncol (2016)
“... with dacomitinib, an oral irreversible pan-human epidermal growth factor receptor (HER) inhibitor, in development...”Publicado no Ann Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Reshma, V, Varsha, BK, Rakesh, P, Radhika, MB, Soumya, M, D’Mello, Sarah
Publicado no J Oral Maxillofac Pathol (2016)
“...INTRODUCTION: Oral submucous fibrosis (OSMF) is graded according to various histological factors...”Publicado no J Oral Maxillofac Pathol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Garcia-Manero, G, Sekeres, M A, Egyed, M, Breccia, M, Graux, C, Cavenagh, J D, Salman, H, Illes, A, Fenaux, P, DeAngelo, D J, Stauder, R, Yee, K, Zhu, N, Lee, J-H, Valcarcel, D, MacWhannell, A, Borbenyi, Z, Gazi, L, Acharyya, S, Ide, S, Marker, M, Ottmann, O G
Publicado no Leukemia (2017)
“...) was designed to determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) of panobinostat...”Publicado no Leukemia (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Booth, Carl D, Crawford, S Michael, Jeyasangar, Ganesan, Daykin, Rebecca
Publicado no Eur J Hosp Pharm (2018)
“... commonly used oral anticancer medicines (OAMs). METHODS: Interviews conducted with a range of non-oncology...”Publicado no Eur J Hosp Pharm (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“...Oral cholecystography is a well established method for studying the human gallbladder...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo